MOHAMMAD SHAMIE: Open Payments
NPI 1699887844 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 56 payments from 10 companies in 2025. Trend: 2023 $1,817 · 2024 $1,189 · 2025 $1,901
Food & beverage: $1,790Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $658 |
| Teva Pharmaceuticals USA, Inc. | 13 | $411 |
| Otsuka America Pharmaceutical, Inc. | 10 | $309 |
| E.R. Squibb & Sons, L.L.C. | 5 | $185 |
| Vanda Pharmaceuticals Inc. | 3 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Lundbeck LLC | 2 | $58 |
| ABBVIE INC. | 1 | $50 |
| Bausch Health US, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: ARISTADA, REXULTI, UZEDY, LYBALVI, COBENFY, HETLIOZ, CAPLYTA, VRAYLAR.
Industry payments across CA — which companies pay providers there.
